GrowGeneration GAAP EPS of $0.00 misses by $0.01, revenue of $44.8M misses by $0.24M (NASDAQ:GRWG)

GrowGeneration (GRWG) reported Q3 GAAP EPS of $0.00, missing estimates by $0.01, and revenue of $44.8M, missing by $0.24M. The company has $41.8M in cash and no debt. GRWG is narrowing its full-year 2026 outlook.

Original reporting
Published Nov 10, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 9:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GRWG
Bearish
high confidence
Mentioned
$GRWG
Relevance
6/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$GRWGBearishMed
01

Why it matters

The modest miss may prompt a short-term sell-off, but the strong balance sheet could mitigate downside.

02

Market read

Earnings miss for a small-cap listed company; likely short-term price impact.

03

What to watch

Cash position of $41.8M and no debt could provide runway despite the miss.

Relevance 6/10Novelty 7/10Timing: after-hours release

Background

GrowGeneration (NASDAQ:GRWG) issued a Q3 earnings press release highlighting a slight miss on EPS and revenue.

Company-level read

Ticker impact

$GRWGBearishHigh confidence
Context

Q3 GAAP EPS of $0.00 missed consensus by $0.01 and revenue of $44.8M missed by $0.24M.

Expected impact

downward pressure as market prices in the EPS and revenue shortfall

Evidence & confidence

Both EPS and revenue fell short of expectations, a typical bearish catalyst for a small-cap stock.

Market effects

Minimal impact on the broader hydroponics/indoor agriculture sector.

Limited to U.S. small-cap investors.

Low

Counterpoint

If the miss is within a narrow range, the stock may rebound on short-covering.

Key entities

  • GrowGeneration

    U.S.-listed indoor agriculture retailer.

Related articles

$GRWGMedAI 8/10

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration Corp. (GRWG) reported Q2 2026 results: a 3-cent per-share loss, narrower than the Zacks Consensus estimate of a 4-cent loss and versus an 8-cent loss a year earlier. Sales rose 5.5% to $43.2M. Adjusted EBITDA was $0.3M. The company raised full-year adjusted EBITDA guidance to $2–$3M and reaffirmed sales guidance of $162–$168M.

$GRWGMedAI 8/10

GrowGeneration Corp. Q2 2026 Earnings Call Summary

GrowGeneration Corp. reported a third straight quarter of YoY revenue growth, citing a shift to a commercial B2B platform and proprietary brands. Proprietary brand penetration reached 40% ahead of schedule. The company cut store and operating expenses 22% YoY and raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, aided by expected Q3 IEPA tariff refunds. It repurchased 700,000 shares at $1.38.

$GRWGMedAI 8/10

GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript

GrowGeneration (GRWG) reported Q2 2026 revenue of $43.2 million, up 5.5% year over year, with adjusted EBITDA of $0.3 million versus a $1.3 million loss a year earlier. Net loss narrowed to $2.0 million. Gross margin rose to 28.5%. Full-year 2026 guidance: revenue $162-$168 million and adjusted EBITDA $2-$3 million. Cash was $41 million with no debt.

$AXONMed

Axon Sinks 27% in a Week to a New 52-Week Low. Is the Selling Overdone?

Axon shares dropped 27% in a week to a 52-week low after missing Q3 revenue estimates and lowering its 2026 outlook due to delayed federal Dedrone deployments. The company now expects $350M-$400M in free cash flow by 2026, down from $450M, and needs $450M in Q4 to meet targets. Competitors Motorola Solutions and Tyler Technologies reported strong demand. Analysts reduced 2027 EPS estimates to $9.55 from $10.51.